• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者如何定义雷诺现象?原发性疾病与继发性疾病之间的差异。

How do patients define Raynaud's phenomenon? Differences between primary and secondary disease.

作者信息

Murphy Susan L, Lescoat Alain, Alore Mary, Hughes Michael, Pauling John D, Sabbagh Maya, Khanna Dinesh

机构信息

Department of Physical Medicine and Rehabilitation, University of Michigan, 24 Frank Lloyd Wright Drive, Lobby M Suite 3100, Ann Arbor, MI, 48105, USA.

VA Ann Arbor Health Care System, Geriatric Research, Education, and Clinical Center (GRECC), 2215 Fuller Rd, Ann Arbor, MI, 48105, USA.

出版信息

Clin Rheumatol. 2021 Apr;40(4):1611-1616. doi: 10.1007/s10067-021-05598-7. Epub 2021 Jan 24.

DOI:10.1007/s10067-021-05598-7
PMID:33486597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8080278/
Abstract

INTRODUCTION/OBJECTIVES: To examine how people define Raynaud's phenomenon (RP) based on their lived experiences and explore if differences exist depending on primary or secondary RP diagnosis.

METHOD

An international survey was sent to people with RP through health systems, foundations, and social media. Qualitative coding of responses to an open text question regarding one's own definition of RP was performed and themes were identified. The prevalence of themes among the sample and then comparisons between themes among people who self-reported primary versus secondary diagnosis of RP were performed.

RESULTS

There were 1345 respondents from 45 countries (mean age 51.5 years, 93% female) who defined RP in their own words; 17% reported primary RP and 83% reported secondary RP (69% of secondary RP was scleroderma-related, n = 927). Over half defined their RP by describing the body parts affected, color changes, pain, and triggers or situations in which an episode occurs. Patients with primary RP more frequently defined RP in terms of its impact on function/quality of life and pain compared to those with secondary RP (34.5% versus 25.3%, respectively, p=0.004; 54.0% versus 46.8%, p=0.05). Patients with secondary RP more frequently included specific body parts, color change, the management of attacks, and other digital vascular complications in their definition of RP.

CONCLUSIONS

We have identified differences in how people with primary and secondary RP define RP, in terms of how they feel and function. Our findings have implications for the domains of outcome measures for assessing RP within different patient populations. Key Points • Pain is more often mentioned in primary RP and color change in secondary RP. • Over 25% of patients included reduced the quality of life as part of their RP definition. • The concept of "attack" is used to define RP by only 2% of patients.

摘要

引言/目的:研究人们如何根据自身经历来定义雷诺现象(RP),并探讨根据原发性或继发性RP诊断是否存在差异。

方法

通过卫生系统、基金会和社交媒体向患有RP的人群发送了一项国际调查。对关于个人对RP定义的开放性文本问题的回答进行定性编码,并确定主题。计算样本中各主题的患病率,然后对自我报告为原发性与继发性RP诊断的人群之间的主题进行比较。

结果

来自45个国家的1345名受访者(平均年龄51.5岁,93%为女性)用自己的语言定义了RP;17%报告为原发性RP,83%报告为继发性RP(继发性RP的69%与硬皮病相关,n = 927)。超过一半的人通过描述受影响的身体部位、颜色变化、疼痛以及发作的触发因素或情况来定义他们的RP。与继发性RP患者相比,原发性RP患者更频繁地根据其对功能/生活质量和疼痛的影响来定义RP(分别为34.5%对25.3%,p = 0.004;54.0%对46.8%,p = 0.05)。继发性RP患者在其RP定义中更频繁地包括特定身体部位、颜色变化、发作的处理以及其他手指血管并发症。

结论

我们已经确定了原发性和继发性RP患者在如何定义RP方面的差异,包括他们的感受和功能。我们的研究结果对评估不同患者群体中RP的结局指标领域具有启示意义。要点 • 原发性RP中疼痛更常被提及,继发性RP中颜色变化更常被提及。 • 超过25%的患者将生活质量下降纳入其RP定义的一部分。 • 仅2%的患者使用“发作”概念来定义RP。

相似文献

1
How do patients define Raynaud's phenomenon? Differences between primary and secondary disease.患者如何定义雷诺现象?原发性疾病与继发性疾病之间的差异。
Clin Rheumatol. 2021 Apr;40(4):1611-1616. doi: 10.1007/s10067-021-05598-7. Epub 2021 Jan 24.
2
Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease.原发性雷诺现象与结缔组织病继发的临床相关差异。
Semin Arthritis Rheum. 2024 Oct;68:152521. doi: 10.1016/j.semarthrit.2024.152521. Epub 2024 Jul 18.
3
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.测量硬皮病和雷诺现象患者的疾病活动度和功能状态。
Arthritis Rheum. 2002 Sep;46(9):2410-20. doi: 10.1002/art.10486.
4
The clinical relevance of Raynaud's phenomenon symptom characteristics in systemic sclerosis.雷诺现象症状特征在系统性硬化症中的临床相关性。
Clin Rheumatol. 2022 Oct;41(10):3049-3054. doi: 10.1007/s10067-022-06206-y. Epub 2022 May 18.
5
Raynaud's phenomenon-an update on diagnosis, classification and management.雷诺现象:诊断、分类和管理的最新进展。
Clin Rheumatol. 2019 Dec;38(12):3317-3330. doi: 10.1007/s10067-019-04745-5. Epub 2019 Aug 16.
6
Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity.雷诺现象在系统性硬化症中的症状特征演变及其与医生和患者报告的疾病严重程度评估的关系。
Arthritis Care Res (Hoboken). 2019 Aug;71(8):1119-1126. doi: 10.1002/acr.23729. Epub 2019 Jul 3.
7
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group.患者对系统性硬化症相关足部雷诺现象的看法:来自 OMERACT 足部和踝关节工作组的定性研究。
Semin Arthritis Rheum. 2024 Apr;65:152372. doi: 10.1016/j.semarthrit.2024.152372. Epub 2024 Feb 2.
8
International consensus criteria for the diagnosis of Raynaud's phenomenon.国际雷诺现象诊断共识标准。
J Autoimmun. 2014 Feb-Mar;48-49:60-5. doi: 10.1016/j.jaut.2014.01.020. Epub 2014 Feb 1.
9
Factors Influencing Patient Decision-Making Concerning Treatment Escalation in Raynaud's Phenomenon Secondary to Systemic Sclerosis.影响系统性硬化症继发雷诺现象患者治疗升级决策的因素。
Arthritis Care Res (Hoboken). 2021 Dec;73(12):1845-1852. doi: 10.1002/acr.24710.
10
Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire.系统性硬化症相关雷诺现象评估问卷(ASRAP)的结构效度和信度
Rheumatology (Oxford). 2024 May 2;63(5):1281-1290. doi: 10.1093/rheumatology/kead371.

引用本文的文献

1
Physical activity, sedentary behaviour and health-related quality of life in 929 women with primary Raynaud's phenomenon.929例原发性雷诺现象女性的体力活动、久坐行为与健康相关生活质量
Clin Rheumatol. 2025 Apr 17. doi: 10.1007/s10067-025-07416-w.
2
Development and validation of the RQLQ: a Raynaud's disease-specific measure of health-related quality of life.RQLQ 的制定与验证:一种用于评估雷诺氏病患者健康相关生活质量的特异性测量工具。
Clin Rheumatol. 2024 Dec;43(12):3963-3972. doi: 10.1007/s10067-024-07175-0. Epub 2024 Oct 11.
3
An Experimental Phototherapy Device for Studying the Effects of Blue Light on Patients with Raynaud's Phenomenon.一种用于研究蓝光对雷诺现象患者影响的实验光疗设备。
Ann Biomed Eng. 2024 Jun;52(6):1732-1743. doi: 10.1007/s10439-024-03487-z. Epub 2024 Mar 26.
4
Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying subgroups.系统性硬皮病患者症状体验的差异:一种识别亚组的聚类分析方法。
Rheumatology (Oxford). 2023 Feb 6;62(SI):SI64-SI73. doi: 10.1093/rheumatology/keac444.
5
Practical management of Raynaud's phenomenon - a primer for practicing physicians.雷诺现象的实用管理——临床医生实用指南。
Curr Opin Rheumatol. 2022 Jul 1;34(4):235-244. doi: 10.1097/BOR.0000000000000877. Epub 2022 Jun 9.
6
Symptom experience of limited cutaneous systemic sclerosis from the Patients' perspective: A qualitative study.局限性皮肤系统性硬皮病患者的症状体验:一项定性研究。
Semin Arthritis Rheum. 2022 Feb;52:151926. doi: 10.1016/j.semarthrit.2021.11.003. Epub 2021 Nov 7.

本文引用的文献

1
Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.雷诺现象患病率的地理差异:五地区比较
J Rheumatol. 1997 May;24(5):879-89.
2
Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France.雷诺现象患病率的地理差异:美国南卡罗来纳州查尔斯顿市与法国萨瓦省塔朗泰斯市对比
J Rheumatol. 1993 Jan;20(1):70-6.